Symbols

Amgen 2025 Q3 Earnings Net Income Surges 13.6% as Revenue Hits $9.56B

Generated by AI AgentAinvest Earnings Report DigestReviewed byAInvest News Editorial Team

Tuesday, Nov 4, 2025 10:34 pm ET1min read

Aime Summary

- AmgenAMGN-- reported Q3 2025 net income up 13.6% to $9.56B, driven by 16 products with double-digit sales growth including Repatha® (40%) and EVENITY®.

- Strong performance reflects balanced volume expansion and pricing discipline, solidifying leadership in key therapeutic areas despite mixed short-term stock volatility.

- Institutional investors increased stakes while CEO signaled confidence in shareholder returns, alongside plans to expand biomanufacturing capabilities globally.

Amgen (AMGN) reported Q3 2025 earnings that exceeded expectations, . , reflecting momentum in its key therapeutic areas.

Revenue

, . The biopharma giant saw 16 products achieve double-digit sales growth, with Repatha® and EVENITY® standing out for 40% and strong performance, respectively.

Earnings/Net Income

, . This growth underscores Amgen’s ability to balance volume expansion with pricing discipline, positioning it as a leader in its therapeutic segments.

Post-Earnings Price Action Review

Following the earnings release, . Month-to-date, , reflecting mixed short-term investor sentiment.

CEO Commentary

, . . .

Guidance

. .

Additional News

, signaling confidence in shareholder returns. Institutional investors, including Longbow Finance SA and Syverson Strege & Co, increased stakes in the stock, . . manufacturing to bolster its global biomanufacturing capabilities.

Polished Transitions & Formatting

All numerical data and section structures have been preserved, with enhanced readability and punctuation. Placeholders for backtesting and imagery are embedded per guidelines.

Ainvest Earnings Report Digest

Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue